Explore more publications!

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on October 6, 2025

Safety Mojo Recognized as Construction Executive 2025 Top Tech Firm
Newsmatics Team to Speak at Mid-Atlantic MarCom Summit on AI’s Impact on News Consumption, Distribution
Cloudfy Awarded Best eCommerce Platform at the eCommerce Awards 2025
Protective Coatings Market Soars as Innovation Drives Demand Across Industrial and Construction Sectors 2025-2032
GenH2 CEO Greg Gosnell to Speak at Hydrogen Day 2025 Event at The University of Texas Energy Institute on October 8
Schneider Industries and Solutions 4 Manufacturing Partner to Auction 1200 TPD Soybean Crush Plant in Greenwood, MS
CORRECTION - Verde AgriTech Announces District Scale High-Grade Magnetic Rare Earths Discovery in Minas Gerais, Brazil
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
New Miami Wellness Startup Makes CEOs Earn Their Seat—Starting With a 90-Minute Trek Through the Woods
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Court Dismisses Key Fraud Allegations in LuxUrban Securities Case, Leaving Narrow Disclosure Dispute According to New Stanford Legal Report
Water Filtration Systems Market Size to Grow from USD 14.23 Billion in 2024 to USD 35.59 Billion by 2034, at a 9.6% CAGR
Interfor to Announce Third Quarter Results on November 6, 2025
Bombardier Completes Redemption for All of its 7.125% Senior Notes due 2026 and Partial Redemption for US$83,711,000 of its 7.875% Senior Notes due 2027
Bombardier mène à bien le rachat de la totalité de ses billets de premier rang 7,125 % échéant en 2026 et le rachat partiel de ses billets de premier rang 7,875 % échéant en 2027 d’un capital de 83 711 000 $ US
Parler Cloud Technologies and Kyvo Launch Global “Invite & Earn” Program — Rewarding Users and Their Referrals with 500 OPT Tokens Each
SPX Technologies to Report Third Quarter 2025 Financial Results
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
Biomed Industries, Inc. to Present Promising NA-921 Phase 2/3 Results for Rett Syndrome Treatment at EAPS 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions